Assignee
HIBERCELL INC
US10 patents
Top patents by PatentIndex Score
US11229701B2Jan 25, 2022
Methods for identifying beta-glucan binding to immune cells
HIBERCELL INC2 citations68
US11667651B2Jun 6, 2023
Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors
HIBERCELL INC1 citations59
US12390526B2Aug 19, 2025
Methods for identifying beta-glucan binding to immune cells
HIBERCELL INC0 citations57
US12006332B2Jun 11, 2024
Aminopyrimidine derivatives as phosphatidylinositol phosphate kinase inhibitors
HIBERCELL INC0 citations52
US11498929B2Nov 15, 2022
Chromenopyrimidine derivatives as phosphatidylinsitol phosphate kinase inhibitors
HIBERCELL INC0 citations52
US12473296B2Nov 18, 2025
Perk inhibiting compounds
HIBERCELL INC0 citations50
US12331054B2Jun 17, 2025
Perk inhibiting imidazolopyrazine compounds
HIBERCELL INC0 citations50
US11584763B2Feb 21, 2023
Chromenopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors
HIBERCELL INC0 citations48
US11919902B2Mar 5, 2024
Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitors
HIBERCELL INC0 citations46
US11815435B2Nov 14, 2023
Beta glucan immunopharmacodynamics
HIBERCELL INC0 citations39